Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc is a pioneering biotechnology firm based in Boston, Massachusetts, focused on creating innovative medicines for cancer and other serious diseases. By harnessing the body's natural processes, it designs small molecule drugs that can precisely eliminate harmful proteins. Its leading projects target a range of conditions, including cancers driven by specific genetic factors, ovarian, uterine, and breast cancers, as well as inflammatory, neurodegenerative, diabetes, liver, and autoimmune diseases. Founded in 2019, Monte Rosa is at the forefront of developing treatments that aim to improve the lives of patients worldwide.